Search Results - "Manzo Margiotta, F"

Long-term drug survival of risankizumab in psoriasis: insights from a real-life multicenter study on hard-to-treat areas by Michelucci, A., Margiotta, F. Manzo, Cartocci, A., Panduri, S., Trovato, E., Calpalbo, E., Dragotto, M., Di Cesare, A., Rosi, E., Rossari, S., Magnano, M., Pescitelli, L., Buggiani, G., Simoni, B., Lorenzoni, E., Ricceri, F., Savarese, I., Milanesi, N., Rubegni, P., Prignano, F., Romanelli, M.

“…Psoriasis, a chronic inflammatory condition, often presents challenges in treatment, particularly in areas such as nails, palms/soles, scalp/face, and…”
Get full text

Family history of psoriasis: a novel protective factor for therapy switch in patients treated with Secukinumab or Ixekizumab by Manzo Margiotta, F., Michelucci, A., Panduri, S., Tonini, A., Davini, G., Romanelli, M., Morganti, R., Dini, V.

Get full text

Real-life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24-week Italian study by Piraccini, B M, Pampaloni, F, Cedirian, S, Quadrelli, F, Bruni, F, Rapparini, L, Caro, G, Acri, M C, Ala, L, Rossi, A, Pellacani, G, Lacarrubba, F, Micali, G, Dall'Oglio, F, Vastarella, M, Cantelli, M, Nappa, P, Diluvio, L, Bianchi, L, Gnesotto, L, Sechi, A, Naldi, L, Tassone, F, Peris, K, Caldarola, G, Pinto, L M, Girolomoni, G, Marangoni, F, Bellinato, F, Gisondi, P, Scandagli, I, Prignano, F, Pimpinelli, N, Tomasini, C, Barruscotti, S, De Simoni, E, Simonetti, O, Ambrogio, F, Foti, C, Boccaletti, V, Fraghì, A, Marzano, A V, Mattioli, M A, Rocca, L, Barbareschi, M, Ferrucci, S M, Gallo, G, Ribero, S, Quaglino, P, Balestri, R, Ioris, T, Caposiena Caro, R D, Zalaudek, I, Vagnozzi, E, Fargnoli, M C, Caponio, C, Rubegni, P, Cinotti, E, Trovato, E, Romanelli, M, Dini, V, Manzo Margiotta, F, Feliciani, C, de Felici Del Giudice, M B, Atzori, L, Sanna, S, Lembo, S, Raimondo, A, Magnano, M, Starace, M

“…Alopecia areata is an autoimmune condition characterized by rapid hair loss in the scalp, eyebrows and eyelashes, for which treatments are limited…”
Get full text